Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors
Clinical trial NCT02508441 · TERMINATED
Trial details
- NCT number
- NCT02508441
- Sponsor
- Andes Biotechnologies
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-08
- Primary completion
- 2017-11-13
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.